Showing 1 - 5 results of 5 for search 'Kinjiro Morimoto', query time: 0.03s Refine Results
  1. 1
    A Novel High-Mannose Specific Lectin from the Green Alga Halimeda renschii Exhibits a Potent Anti-Influenza Virus Activity through High-Affinity Binding to the Viral Hemagglutinin

    A Novel High-Mannose Specific Lectin from the Green Alga Halimeda renschii Exhibits a Potent Anti-Influenza Virus Activity through High-Affinity Binding to the Viral Hemagglutinin by Jinmin Mu, Makoto Hirayama, Yuichiro Sato, Kinjiro Morimoto, Kanji Hori

    Published 2017-08-01
    Get full text
    Article
  2. 2
    Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral Hemagglutinin

    Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral Hemagglutinin by Yuichiro Sato, Kinjiro Morimoto, Takanori Kubo, Takemasa Sakaguchi, Akira Nishizono, Makoto Hirayama, Kanji Hori

    Published 2015-05-01
    Get full text
    Article
  3. 3
    High Mannose Binding Lectin (PFL) from <i>Pseudomonas fluorescens</i> Down-Regulates Cancer-Associated Integrins and Immune Checkpoint Ligand B7-H4

    High Mannose Binding Lectin (PFL) from <i>Pseudomonas fluorescens</i> Down-Regulates Cancer-Associated Integrins and Immune Checkpoint Ligand B7-H4 by Yuichiro Sato, Kiminori Matsubara, Takanori Kubo, Hirobumi Sunayama, Yuta Hatori, Kinjiro Morimoto, Toshio Seyama

    Published 2019-04-01
    Get full text
    Article
  4. 4
    Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.

    Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge. by Mutsuyo Takayama-Ito, Chang-Kweng Lim, Yukie Yamaguchi, Guillermo Posadas-Herrera, Hirofumi Kato, Itoe Iizuka, Md Taimur Islam, Kinjiro Morimoto, Masayuki Saijo

    Published 2018-04-01
    Get full text
    Article
  5. 5
    Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.

    Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice. by Hirofumi Kato, Mutsuyo Takayama-Ito, Itoe Iizuka-Shiota, Shuetsu Fukushi, Guillermo Posadas-Herrera, Madoka Horiya, Masaaki Satoh, Tomoki Yoshikawa, Souichi Yamada, Shizuko Harada, Hikaru Fujii, Miho Shibamura, Takuya Inagaki, Kinjiro Morimoto, Masayuki Saijo, Chang-Kweng Lim

    Published 2019-01-01
    Get full text
    Article

Search Tools: